Modulating metabolic signatures to mitigate cabozantinib resistance in FLT3-ITD acute myeloid leukemia cell models
Yu-Hsuan Fu(National Taiwan University), Liang‐In Lin(National Taiwan University)
Cited by 0
Related Papers
The development of hypocretin (OREXIN) deficiency in hypocretin/ataxin-3 transgenic rats
|Neuroscience|2007|55
Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis
|Biomedicines|2021|13
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|Cancer Gene Therapy|2021|11